Linezolid was introduced by the World Health Organization (WHO) in 2022, as part of the BPaLM regimen, also comprising ...

The newly published results of two small clinical trials suggest that two novel antibiotics could provide safer alternatives ...

Tuberculosis remains the world's leading infectious killer, resulting in more than 1·25 million deaths in 2023 alone.1 During ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

DOH Usec. Abdullah B. Dumama Jr, Cluster Lead of the National UHC Health Services Cluster (UHC-HSC) and concurrent head of ...

Physicians who champion immunization sustain herd immunity, reducing the incidence of severe diseases, hospitalizations, and ...

DeepTek’s AI-based chest X-ray solution meets WHO performance standards for computer-aided detection in tuberculosis ...

Tamil Nadu integrates predictive model to reduce TB deaths, prioritizing severely ill patients for prompt hospital admission.

Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to supply a long-acting HIV prevention drug to low-income countries, despite the ...